EDAP TMS holds FocalTherics Investor Day; plans to exit ESWL and distribution segments to focus on HIFU

EDAP TMS SA

Presentation at June 1, 2026 Investor Day highlights strategic shift to High Intensity Focused Ultrasound (HIFU) devices.
Company intends to discontinue Extracorporeal Shock Wave Lithotripsy (ESWL) and distribution operating segments.
FocalTherics (Nasdaq: FOCL) is the new corporate branding; no financial results or guidance disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.